Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Neurology
|
March 6, 2023
Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials
Vignan Yogendrakumar, Leonid Churilov, Peter J Mitchell, et al.
Cell Reports
|
May 3, 2018
CSF1R<sup>+</sup> Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
Juliana B Candido, Jennifer P Morton, Peter Bailey, et al.
Nature
|
March 13, 2025
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC
Elena Fiorini, Antonia Malinova, Daniel Schreyer, et al.
Neurology
|
January 7, 2021
Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion
Fana Alemseged, Felix C Ng, Cameron Williams, et al.
Cell Reports. Medicine
|
November 5, 2022
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
Mark P G Dings, Amber P van der Zalm, Sanne Bootsma, et al.
Cancer Cell
|
September 19, 2019
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
Rene Jackstadt, Sander R van Hooff, Joshua D Leach, et al.
Communications Medicine
|
May 17, 2024
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma
Amber P van der Zalm, Mark P G Dings, Paul Manoukian, et al.
Translational Oncology
|
September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response
Jingyu An, Roma Kurilov, Teresa Peccerella, et al.
Cancer Cell
|
June 7, 2016
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W Steele, Saadia A Karim, Joshua D G Leach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2024
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Daniel H Palmer, Richard Jackson, Christoph Springfeld, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Neurology
|
March 6, 2023
Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials
Vignan Yogendrakumar, Leonid Churilov, Peter J Mitchell, et al.
Cell Reports
|
May 3, 2018
CSF1R<sup>+</sup> Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
Juliana B Candido, Jennifer P Morton, Peter Bailey, et al.
Nature
|
March 13, 2025
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC
Elena Fiorini, Antonia Malinova, Daniel Schreyer, et al.
Neurology
|
January 7, 2021
Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion
Fana Alemseged, Felix C Ng, Cameron Williams, et al.
Cell Reports. Medicine
|
November 5, 2022
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
Mark P G Dings, Amber P van der Zalm, Sanne Bootsma, et al.
Cancer Cell
|
September 19, 2019
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
Rene Jackstadt, Sander R van Hooff, Joshua D Leach, et al.
Communications Medicine
|
May 17, 2024
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma
Amber P van der Zalm, Mark P G Dings, Paul Manoukian, et al.
Translational Oncology
|
September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response
Jingyu An, Roma Kurilov, Teresa Peccerella, et al.
Cancer Cell
|
June 7, 2016
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W Steele, Saadia A Karim, Joshua D G Leach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2024
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Daniel H Palmer, Richard Jackson, Christoph Springfeld, et al.
Page
of 9